tiprankstipranks
Biostar Pharmaceuticals (BSPM)
OTHER OTC:BSPM
US Market

Biostar Pharmaceuticals (BSPM) Price & Analysis

54 Followers

BSPM Stock Chart & Stats

$0.05
$0.00(0.00%)
At close: 4:00 PM EDT
$0.05
$0.00(0.00%)

BSPM FAQ

What was Biostar Pharmaceuticals’s price range in the past 12 months?
Biostar Pharmaceuticals lowest stock price was $0.05 and its highest was $0.05 in the past 12 months.
    What is Biostar Pharmaceuticals’s market cap?
    Biostar Pharmaceuticals’s market cap is $264.00.
      When is Biostar Pharmaceuticals’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Biostar Pharmaceuticals’s earnings last quarter?
      Biostar Pharmaceuticals released its earnings results on Apr 13, 2017. The company reported -$0.38 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.38.
        Is Biostar Pharmaceuticals overvalued?
        According to Wall Street analysts Biostar Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Biostar Pharmaceuticals pay dividends?
          Biostar Pharmaceuticals does not currently pay dividends.
          What is Biostar Pharmaceuticals’s EPS estimate?
          Biostar Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Biostar Pharmaceuticals have?
          Biostar Pharmaceuticals has 2,637,000 shares outstanding.
            What happened to Biostar Pharmaceuticals’s price movement after its last earnings report?
            Biostar Pharmaceuticals reported an EPS of -$0.38 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of Biostar Pharmaceuticals?
              Currently, no hedge funds are holding shares in BSPM
              What is the TipRanks Smart Score and how is it calculated?
              Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                Company Description

                Biostar Pharmaceuticals

                Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. In addition, the company provides prescription pharmaceutical products, including Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. It sells its products through distributors and website that serves as internet-based China Hepatitis Internet Hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.

                Biostar Pharmaceuticals (BSPM) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Sonoma Pharmaceuticals
                Sunshine Biopharma
                PainReform
                Universe Pharmaceuticals
                Shuttle Pharmaceuticals Holdings, Inc.

                Ownership Overview

                0.34%99.66%
                Insiders
                Mutual Funds
                0.34% Other Institutional Investors
                99.66% Public Companies and
                Individual Investors
                Popular Stocks